β-Amyloid (1-17)
|
|
186319-72-2
|
Bcl-2-IN-2
|
|
2383085-86-5
|
Phenylacetic acid mustard
|
|
10477-72-2
|
HKSOX-1
|
|
1786411-17-3
|
(±)-2,3-Dibromosuccinic acid
|
|
1114-00-7
|
LY 541850
|
|
852679-76-6
|
Opigolix
|
|
912587-25-8
|
4,7,10,13,16-Docosapentaenoic acid
|
|
2313-14-6
|
Docusate-d
|
|
175736-89-7
|
Berberine ursodeoxycholate
|
|
1868138-66-2
|
Imiclopazine
|
|
7414-95-1
|
Ciraparantag TFA
|
|
1438492-27-3
|
DCZ3301
|
|
2136278-38-9
|
8(14)-Abietenic acid
|
|
19407-37-5
|
D13-9001
|
|
957471-96-4
|
DSM421
|
|
2011769-21-2
|
PF-05198007
|
|
1642112-31-9
|
Asthma relating compound 1
|
|
120165-51-7
|
Tubulysin I
|
|
799822-10-9
|
Vornorexant
|
|
1517965-94-4
|
Bax BH3 peptide (55-74), wild type
|
|
299946-20-6
|
Tricin 7-O-glucuronide
|
|
32769-02-1
|
Tauroxicum
|
|
648922-41-2
|
Hypoglycemic agent 1
|
|
2253733-57-0
|
Elisartan
|
|
149968-26-3
|
Erythropterin
|
|
7449-03-8
|
Tazomeline
|
|
131987-54-7
|
H2N-PEG4-Hydrazide
|
|
1425973-15-4
|
RXFP3/4 agonist 1
|
|
2351104-40-8
|
TFAX 568, SE
|
|
878549-44-1
|
K-8012
|
|
1346513-17-4
|
Compound 2
|
|
872313-42-3
|
N-(Biotin-PEG4)-N-bis(PEG4-Boc)
|
|
2112730-79-5
|
BnOH-NH-bis-(C2-S)-propane-O-isoprene ester
|
|
2448704-23-0
|
Tetrachloroveratrole
|
|
944-61-6
|
Monooctyl succinate
|
|
74295-86-6
|
Glycerol derivative 1
|
|
128400-55-5
|
Ganglioside GM3 sodium salt
|
|
185384-74-1
|
BAY-7598
|
|
1816257-74-5
|
Bz-Lys-OMe
|
|
17039-40-6
|
SB-267268
|
|
205678-26-8
|
Cholesterol glucuronide
|
|
17435-78-8
|
4,5-Dichloroguaiacol
|
|
2460-49-3
|
Methylnaltrexone D3 Bromide
|
|
1131456-47-7
|
Ganglioside GD3 disodium salt
|
|
497932-19-1
|
RT-AM
|
|
2280796-94-1
|
Pip-alkyne-Ph-COOCH3
|
|
2308496-47-9
|
1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-phenylurea
|
|
1144075-42-2
|
Cyclopentyluracil
|
|
59967-83-8
|
Tubulysin F
|
|
368870-67-1
|
Hydroxypyruvic acid lithium hydrate
|
|
209728-15-4
|
FGFR4-IN-4
|
|
2230973-67-6
|
1-(2-hydroxyethyl)thymine
|
|
22441-51-6
|
Ibezapolstat hydrochloride
|
|
1275582-98-3
|
SQI-Pr
|
|
1022595-16-9
|
Elvitegravir-d
|
|
957889-73-5
|
(+)-Guaiacin
|
|
88547-66-4
|
PCC0208017
|
|
2623158-64-3
|
Itch-Targeting Compound 1
|
|
793674-76-7
|
4'-Raloxifene-β-D-glucopyranoside
|
|
334758-19-9
|
TT-OAD2
|
|
2382719-60-8
|
N6-(p-Hydroxyphenethyl)-Adenosine)
|
|
41552-94-7
|
Aldehyde-benzyl-PEG5-alkyne
|
|
1378928-83-6
|
(Z)-MDL 105519
|
|
179105-67-0
|
Arrhythmic-Targeting Compound 1
|
|
136079-82-8
|
Pirepemat
|
|
1227638-29-0
|
CP-96021 hydrochloride
|
|
167011-22-5
|
AM-6494
|
|
1874232-80-0
|
USP7-IN-5
|
|
2166599-74-0
|
HKOCl-4m
|
|
2031170-88-2
|
F8-S43-S3
|
|
2719679-31-7
|
Cyclobenzaprine-d
|
|
82857-38-3
|
T-2513
|
|
288247-87-0
|
PYBG-TMR
|
|
2067339-51-7
|
HKSOX-1m
|
|
1802684-30-5
|
Mal-amide-PEG2-oxyamine-Boc
|
|
2253965-15-8
|
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-carboxamide
|
|
2238820-26-1
|
YM158 free base
|
|
179102-65-9
|
6-Raloxifene-β-D-glucopyranoside
|
|
334758-18-8
|
EC1454
|
|
1602487-15-9
|
5-HT2A receptor agonist-2
|
|
1782228-83-4
|
Zoliprofen
|
|
56355-17-0
|
(S)-2-(1-(2-chloro-4-(pyrrolidin-1-yl)benzoyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl)-N-isopropylacetamide
|
|
192514-57-1
|
4,5,6-Trichloroguaiacol
|
|
2668-24-8
|
FT-001
|
|
1778655-51-8
|
Hydrocortisone phosphate
|
|
3863-59-0
|
Bromoacetamide-PEG3-C1-acid
|
|
173323-22-3
|
Naltriben mesylate
|
|
122517-78-6
|
Setmelanotide acetate
|
|
1504602-49-6
|
CH-0793076
|
|
534605-78-2
|
17-AEP-GA
|
|
75747-23-8
|
AKOS025692697
|
|
1606572-10-4
|
3,4-Dichlorocatechol
|
|
3978-67-4
|
Direct Black 38 free acid
|
|
22244-14-0
|
ND-322 HCl
|
|
1333379-23-9
|
Kemptide TFA
|
|
160414-77-7
|
Diadenosine pentaphosphate pentalithium
|
|
94108-02-8
|
Nebentan
|
|
403604-85-3
|
HMG499
|
|
2416941-68-7
|
8-Bromoadenosine 5'-triphosphate tetrasodium
|
|
35892-96-7
|